Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
Two large-cap pharmaceutical stocks with a solid dividend yield
06:38am, Friday, 27'th May 2022
With healthcare costs rising in the U.S., it seems as if the new drugs will have to follow suit. Big.
7 High-Yield Retirement Stocks to Buy for Your Nest Egg
06:00pm, Thursday, 26'th May 2022
These 7 high-yield retirement stocks to buy are among a list of companies that are dividend aristocrats and offer great dividends. The post 7 High-Yield Retirement Stocks to Buy for Your Nest Egg appe
Best Health Care Stocks To Invest In 2022? 3 Names To Watch
12:30pm, Thursday, 26'th May 2022
Here are 3 top health care stocks to watch in the stock market right now.
Amgen (AMGN) Ahead of Industry This Year So Far: What's Next?
11:51am, Thursday, 26'th May 2022 Zacks Investment Research
Amgen's (AMGN) key drugs like Prolia, Repatha, Xgeva and biosimilars are driving sales. Amgen is also rapidly advancing its robust pipeline of early and late-stage assets.
7 Ideal Dividend Stocks to Buy for a Rich Retirement
10:41am, Thursday, 26'th May 2022
These dividend stocks to buy will enable you to offset your portfolio risk. The post 7 Ideal Dividend Stocks to Buy for a Rich Retirement appeared first on InvestorPlace.
3 Healthcare Stocks You Can Buy and Hold for the Next Decade
10:00am, Thursday, 26'th May 2022 The Motley Fool
They're leaders in their fields.
Why Did Warren Buffett Just Sell 1 of His Best Stocks of 2022?
09:57am, Thursday, 26'th May 2022 The Motley Fool
The legendary investor just might regret selling this big-pharma stock.
3 Healthcare Stocks You Can Buy and Hold for the Next Decade
06:00am, Thursday, 26'th May 2022
They're leaders in their fields.
SpringWorks (SWTX) Down Despite Desmoid Tumors Study Meeting Goal
04:05pm, Wednesday, 25'th May 2022 Zacks Investment Research
SpringWorks' (SWTX) phase III study evaluating its investigational candidate, nirogacestat, in adult patients with progressing desmoid tumors, meets primary and key secondary endpoints.
2 Dividend Kings That Are Soundly Beating the Market in 2022
03:00pm, Wednesday, 25'th May 2022 The Motley Fool
These stocks could be good places to park your money.
Bristol Myers Squibb Vs. AbbVie: Who Better Fits Our Barbell?
01:37pm, Wednesday, 25'th May 2022
Both Bristol Myers Squibb and AbbVie spark interest for income- and value-oriented investors. You will see why we favor AbbVie as a better fit for our barbell strategy to build an enduring portfolio f
2 Dividend Kings That Are Soundly Beating the Market in 2022
11:00am, Wednesday, 25'th May 2022
These stocks could be good places to park your money.
3 Recession-Proof Stocks To Protect Your Portfolio From Fed-Induced Turmoil
09:38am, Wednesday, 25'th May 2022 Investing.com
Why High Dividend ETFs are Beating the Market
05:02pm, Tuesday, 24'th May 2022 Zacks Investment Research
We highlight 3 ETFs with juicy dividend yields and excellent performance
3 Great Dividend Stocks to Buy Now and Hold
04:04pm, Tuesday, 24'th May 2022 Zacks Investment Research
The episode explores three strong dividend-paying stocks from three different areas of the economy that investors might want to consider buying during the market downturn and holding for the long run.
